sounds good "ChemoCentryx (CCXI), up 10.3% after announcing positive top-line data from two steps of a Phase II trial for the company's blood vessel inflammation treatment" should see a nice run tomorrow. Thanx for the heads up. Yahoo was really screwed up today.
they were badly beaten down earlier this fall when GSK released CCXI from their previous vercirnon alliance deal. No one thought the rest of the pipeline had much promise if GSK wasn't interested. Neither CCX-354(phase II proof of concept) nor CCX-168 had been tested further under the previous GSK deal and until recently phase II on 168 is showed promising results. $15 target if all goes well. Just goes to show you sometimes partnering up with the big guys isn't a means of getting stuff done faster. CCX-140 plus 4 other drugs are in various stages of testing phases. A lot going on for a $5-$6 stock. May chase some in the morning.